FDA OKs Buprenorphine Implant To Treat Opioid Addiction
The U.S. Food and Drug Administration on Thursday approved Probuphine, an implant that provides buprenorphine to treat opioid addiction in six-month stretches, as an alternative to the now-available daily pill or...To view the full article, register now.
Already a subscriber? Click here to view full article